tert-Butyl (3S,4S)-3-(aminomethyl)-4-hydroxypyrrolidine-1-carboxylate

Catalog No. :
ACUSRX105
CAS No. :
872717-45-8
Molecular Formula :
C10H20N2O3
Molecular Weight :
216.28

IUPAC Name:tert-butyl (3S,4S)-3-(aminomethyl)-4-hydroxypyrrolidine-1-carboxylate

tert-Butyl (3S,4S)-3-(aminomethyl)-4-hydroxypyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$501.00Login to see priceIn stockInquiry
250mg95%$800.00Login to see priceIn stockInquiry
500mg95%$1334.00Login to see priceInquiryInquiry
1g95%$2000.00Login to see priceInquiryInquiry
5g95%$5999.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (3S,4S)-3-(aminomethyl)-4-hydroxypyrrolidine-1-carboxylate
IUPAC Nametert-butyl (3S,4S)-3-(aminomethyl)-4-hydroxypyrrolidine-1-carboxylate
MDL No.MFCD23105804
Molecular FormulaC10H20N2O3
Molecular Weight216.28
SMILESO=C(N1C[C@H](CN)[C@H](O)C1)OC(C)(C)C
InChI KeyAHJZEZIYOBGVSK-JGVFFNPUSA-N
Synonymtert-butyl cis-3-(aminomethyl)-4-hydroxypyrrolidine-1-carboxylate | cis-1-Boc-3-(Aminomethyl)-4-Hydroxypyrrolidine | TERT-BUTYL (3S,4S)-3-(AMINOMETHYL)-4-HYDROXYPYRROLIDINE-1-CARBOXYLATE | 1-Pyrrolidinecarboxylic acid, 3-(aminomethyl)-4-hydroxy-,1,1-dimet
CAS No.872717-45-8
PubChem CID59254357

Synthetic Route by SureRoute

1. ACUSRX105 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUSRX105 route product structure diagram
    ACUSRX105872717-45-8 In Stock
Inquiry

2. ACUSRX105 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Then
  5. ACUSRX105 route product structure diagram
    ACUSRX105872717-45-8 In Stock
Inquiry

Comments (0)